INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/27/2025
Back to search
Official data from USPTO
DRAINAD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
09/28/2025
Trademark type
Word
Nice classes
1, 5
Filing date
09/30/2016
Registration date
02/27/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/13/2024
Last transaction
09/28/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
DE
Examiner
O'BRIEN, JENNIFER
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Immungenetics AG
Representatives
Holiday W. Banta Ice Miller LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products for the production of viralretroviral and non-viral vectors
Class 5
Biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazinefor use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazinefor use in dementia disorders and their earlier stagesin particular for use in Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposesin particular those with the active ingredient thiethylperazinefor prevention against neurodegenerative diseases; biochemical and chemical preparations for medical purposesin particular those with the active ingredient thiethylperazinefor preventing dementia disorders and their earlier stagesin particular for preventing Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposesin particular those with the active ingredient thiethylperazinefor the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration formspillstabletsdragéescapsulesliquidsdropsin particular including as active ingredient thiethylperazinefor the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration formpillstabletsdragéescapsulesliquidsdropsin particular including as active ingredient thiethylperazinefor the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposesin particular those with the active ingredient thiethylperazinefor the treatment of dementia disorders and their earlier stagesin particular for the treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes in parenteral administration forminjection solutions and infusion solutionsin particular including as active ingredient thiethylperazinefor the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration formsinjection solutions and infusion solutionsin particular including as active ingredient thiethylperazinefor the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment
Publications
History of USPTO decisions and trademark events.
34 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/05/2025
INPC
INVALIDATION PROCESSED
09/05/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/13/2025
C71T
CANCELLED SECTION 71
09/13/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/27/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/20/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/26/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/29/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/04/2018
FIMP
FINAL DISPOSITION PROCESSED
06/04/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/27/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
02/27/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/21/2018
PUBO
PUBLISHED FOR OPPOSITION
12/12/2017
GPNX
NOTIFICATION PROCESSED BY IB
12/08/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/22/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/22/2017
NPUB
NOTICE OF PUBLICATION
11/22/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2017
ALIE
ASSIGNED TO LIE
10/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/29/2017
RFNT
REFUSAL PROCESSED BY IB
06/03/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/18/2017
RFRR
REFUSAL PROCESSED BY MPU
05/18/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/10/2017
CNRT
NON-FINAL ACTION WRITTEN
05/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
05/06/2017
DOCK
ASSIGNED TO EXAMINER
05/02/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/27/2017
Continuous trademark protection
Get notified about every new filing that threatens DRAINAD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.